Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Olmesartan Versus Nebivolol in Management of Hypertension in Acute Ischemic Stroke

NCT03655964 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.

NCT NCT03655964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03655964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Olmesartan Versus Nebivolol in Management of Hypertension in Acute Ischemic Stroke
Lead sponsor
Aristotle University Of Thessaloniki
Phase
Phase 2
Overall status
Completed
Start date
August 20, 2018
Completion date
August 20, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, ischemic